WASHINGTON, Oct. 22 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Tides Medical LLC from its Center for Biologics Evaluation and Research:

* * *

Recipient: Joe Spell, Chief Executive Officer, Tides Medical LLC, 605 Kaliste Saloom Road, Suite 1, Lafayette, LA 70508, United States, jspell@tidesmedical.com

Issuing Office: Center for Biologics Evaluation and Research (CBER), Uni . . .

Click here for more information about our products